Abstract
Stable flow cytometric markers for malignant myeloid cells are highly warranted. Based on data from stem cell research, we hypothesized that the human inhibitory C-type lectin like receptor (hMICL) might represent a novel diagnostic and prognostic vehicle in a standard flow cytometry (FCM) setting.
Original language | English |
---|---|
Pages (from-to) | 3-8 |
Number of pages | 6 |
Journal | Cytometry Part B: Clinical Cytometry |
Volume | 82B |
Issue number | 1 |
Early online date | 30 Aug 2011 |
DOIs | |
Publication status | Published - Jan 2012 |
Keywords
- AML
- hMICL
- immunophenotyping
- LAIP
- MRD